HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Harvard Apparatus Regenerative Technology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026
- Market cap
- $38.92M
- P/E (TTM)
- –
- Dividend yield
- –
Harvard Apparatus Regenerative Technology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Market Cap | $38.92M | $230.55M |
| Enterprise Value | $38.57M | $202.97M |
| PS Ratio | 39.64 | 3.11 |
Enterprise value
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| EV / Sales | 39.28 | 2.92 |
Income (trailing twelve months)
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Revenue | $982.00K | $102.39M |
| Gross Profit | $74.00K | $60.36M |
| Operating Income | -$6.71M | -$4.31M |
| Net Income | -$6.68M | -$6.57M |
| EBITDA | -$6.71M | -$1.98M |
| EPS (Diluted) | -$0.39 | -$0.07 |
Margins
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Gross Margin | 7.54% | 55.1% |
| Operating Margin | -683.3% | -6.04% |
| Profit Margin | -680.6% | -10.5% |
| EBITDA Margin | -683.3% | -2.67% |
Returns
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Return on Assets (ROA) | -349.7% | -13.3% |
Growth
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 44.6% | 8.85% |
Balance sheet
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $351.00K | $37.33M |
| Net Cash (Debt) | $351.00K | $3.92M |
| Net Cash Per Share | $0.02 | $0.28 |
| Equity (Book Value) | -$1.38M | $57.36M |
| Book Value Per Share | -$0.08 | $2.81 |
| Tangible Book Value | -$1.38M | $10.71M |
| Working Capital | -$2.25M | $54.64M |
Financial position
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Current Ratio | 0.26 | 2.50 |
| Quick Ratio | 0.12 | 1.54 |
| Interest Coverage | -516.15 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Operating Cash Flow | -$3.64M | -$653.46K |
Efficiency
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Asset Turnover | 0.51 | 0.59 |
| Inventory Turnover | 67.26 | 2.21 |
| Revenue Per Employee | $122.75K | $322.57K |
| Profits Per Employee | -$835.38K | -$51.88K |
| Employee Count | 8 | 185 |
Dividends and yields
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Earnings Yield | -17.2% | -6.91% |
Shares
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Shares Outstanding | 17,580,700 | 44,856,700 |
| Shares Change (YoY) | 10.5% | 3.35% |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 13,724,900 | 37,097,900 |
| Shares Held by Insiders | 21.9% | 10.6% |
Scores
| Measure | Harvard Apparatus Regenerative Technology | Industry median |
|---|---|---|
| Altman Z-Score | -97.81 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Harvard Apparatus Regenerative Technology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.